Sangamo BioSciences | SGMO - Despesas De Vendas E Administração





Despesas De Vendas E Administração Alterar Data
Alaunos Therapeutics USD 424K 23K 2026-06
Alnylam Pharmaceuticals USD 342M 5.92M 2026-09
Alterity Therapeutics Limited AUD 1.45M 703.96K 2025-12
Amgen USD 1.72B 134M 2026-06
Bayer EUR 3.96B 267M 2026-06
BioCryst Pharmaceuticals USD 63.98M 31.8M 2026-06
Biogen USD 752M 42.3M 2026-09
BioMarin Pharmaceutical USD 333.64M 61.91M 2026-09
Cipla INR 13.25B 101.8M 2025-12
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.44M 5K 2026-06
CSL USD 1.23B 498M 2025-12
Gilead Sciences USD 1.52B 70M 2026-06
GlaxoSmithKline GBP 2.16B 39M 2026-09
Grifols EUR 320.45M 12.65M 2025-12
Ionis Pharmaceuticals USD 130.07M 20.92M 2026-06
J&J USD 6.25B 168M 2026-09
Karyopharm Therapeutics USD 10.42M 861K 2026-03
Merck USD 2.86B 25M 2026-09
Novartis USD 3.08B 163M 2026-09
Omeros USD 11.32M 2.48M 2024-09
Pfizer USD 3.28B 132M 2026-09
Roche Holding CHF 6.37B 908M 2026-06
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Sanofi EUR 2.31B 325M 2026-09
Sarepta Therapeutics USD 107.6M 53.57M 2026-06
Tectonic Therapeutic USD 6.17M 260K 2026-06
Ultragenyx Pharmaceutical USD 88M 0 2026-06
Vertex Pharmaceuticals USD 556.3M 25.9M 2026-09